KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases
Dr Marina Garassino - National Tumor Institute, Milan, Italy
15 Apr 2019
MYSTIC: Developing biomarkers for metastatic NSCLC
Prof Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switze...
11 Apr 2019
TATTON: Updated results for patients with EGFR-mutant NSCLC
Prof Leica Sequist - Massachusetts General Hospital, Boston, USA
11 Apr 2019
KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lu...
Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea
11 Apr 2019
Perception of tobacco use in young adults of urban India
Ms Soumita Ghose - Tata Medical Centre, Kolkata, India
28 Mar 2019
Nivolumab in combination with CIMAvax-EGF for lung cancer
Dr Grace Dy - Roswell Park Cancer Institute, USA
4 Jan 2019
Large food and alcohol companies are undermining public health
Prof Rob Moodie, Melbourne School of Population and Global Health, Malawi Colleg...
6 Nov 2018
Alcohol consumption and cognitive dissonance in the west
Prof Terry Slevin, Public Health Association of Australia
6 Nov 2018
Using genetics to close the knowledge gap on cancer causation
Dr Paul Brennan, International Agency for Research On Cancer (IARC) (France
6 Nov 2018
The IMpower-132 trial for non small cell lung cancer
Dr Vassiliki Papadimitrakopoulou - University of Texas MD Anderson Cancer Center...
29 Oct 2018
Current clinical landscape for ALK non-small cell lung cancer patients
Dr Riyaz Shah and Dr Maurice Perol
26 Oct 2018
Latest advances in treatment for ALK positive NSCLC
Prof Gordon McVie, Dr Lázaro Quintela
26 Oct 2018
